16 records – page 1 of 1.

Select Title Policy Type Year
EspAddText
EspRemoveText
CMA 2022 Pre-Budget Submission Parliamentary submission 2021
EspAddText
EspRemoveText
CMA Letter - Bill C-30 Implementation Parliamentary submission 2021
EspAddText
EspRemoveText
Policy Brief: CSAM-SMCA in Support of the Decriminalization of Drug Use and Possession for Personal Use Policy endorsement 2021
EspAddText
EspRemoveText
National Approach to Licensure Parliamentary submission 2021
EspAddText
EspRemoveText
Consensus statement on networks for high-quality rural anesthesia, surgery, and obstetric care in Canada Policy endorsement 2021
EspAddText
EspRemoveText
Learning from the pandemic – Transforming and improving Quebec’s health care system Parliamentary submission 2021
EspAddText
EspRemoveText
Response to “Consultation Document – Disability Tax Credit Public Consultations” CMA Submission to Canada Revenue Agency Parliamentary submission 2014
EspAddText
EspRemoveText
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act) Parliamentary submission 2014
EspAddText
EspRemoveText
Tamper Resistance under the Controlled Drugs and Substances Act Response to consultation 2014
EspAddText
EspRemoveText
Proposed amendments to the marihuana for medical purposes regulations Response to consultation 2014
EspAddText
EspRemoveText
Bill C-17 An Act to amend the Food and Drugs Act Parliamentary submission 2014
EspAddText
EspRemoveText
Bill C-422 An Act respecting a National Lyme Disease Strategy Parliamentary submission 2014
EspAddText
EspRemoveText
The Health risks and harms associated with the use of marijuana Parliamentary submission 2014
EspAddText
EspRemoveText
Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase Parliamentary submission 2014
EspAddText
EspRemoveText
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety Parliamentary submission 2014
EspAddText
EspRemoveText
Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations Response to consultation 2014

16 records – page 1 of 1.